Winnipeg

Winnipeg has emerged as a high-growth life sciences hub in North America, uniquely positioned at the intersection of biopharmaceutical manufacturing and cutting-edge infectious disease research.

As the home of the National Microbiology Laboratory (NML), Canada’s only Level 4 high-containment facility, Winnipeg is a global leader in vaccine development and public health innovation.

The city’s robust biotechnology sector is anchored by industry giants like Bausch Health, driving significant advancements in specialty pharmaceuticals and sterile manufacturing.

Beyond pharma, Winnipeg excels in medical device innovation, leveraging a collaborative ecosystem where the University of Manitoba and Health Sciences Centre (HSC) integrate academic research with real-world clinical applications.

The region’s competitive R&D tax incentives and low operating costs make it an attractive destination for life sciences investment and biotech startups.

Healthcare delivery is further transformed by the George & Fay Yee Centre for Healthcare Innovation, which pioneers patient-oriented research and data analytics.

With a highly skilled workforce fueled by world-class institutions, Winnipeg offers a seamless pipeline from drug discovery to global commercialization.

This integrated approach ensures that Manitoba remains a critical player in the global healthcare supply chain and medical technology landscape.